From a technical analysis perspective, the stem stock forecast 2025 shows a long-term uptrend, with sustained support at the $38 level and resistance forming near $52, aligning with volume spikes in biotech. While AI may interact with us through software, it still relies on a physical backbone – processor chips, server stacks, and device interfaces that bring it to life. Bernstein analyst Mark Newman understands this dynamic and has been closely watching the AI hardware sector. Additional information about the reverse stock split can be found in the Proxy Statement and on the Company's Investor Relations website at investors.stem.com. On a quarterly revenue trend basis, the stem stock forecast 2025 anticipates sequential growth above 5%, outpacing sector medians in medical biotechnology.